Skip to main content

Day: June 1, 2020

Boulder AI appoints new VP of Global Sales to Support Company Growth

Boulder, Colorado, June 01, 2020 (GLOBE NEWSWIRE) — Boulder AI, an AI driven IoT hardware and software startup company with an innovative visual intelligence platform, has announced that as a part of their rapid growth plan, the company has appointed industry veteran and serial entrepreneur, Patrick Reilly, as its first Global VP of Sales and Marketing.“Patrick knows how to approach our market and he’s experienced in building processes and support systems,” said Bryan Schmode, CEO of Boulder AI. “We’re thrilled to have him join our team as we transition to the next phase of business growth.”Reilly has three decades of experience helping scale high-tech firms. He has held executive level sales and marketing positions with industry-leading companies, selling six companies when they ended with a successful merger/acquisition for substantial...

Continue reading

ISSUE OF CONVERTIBLE NOTES AND WARRANTS AND CONVERSION OF CONVERTIBLE NOTES PURSUANT TO FINANCING ARRANGEMENT BETWEEN VALOE AND WINANCE

Valoe Corporation                                                  Stock Exchange Release 1 June 2020 at 16.40 (Finnish time)The Board of Directors of Valoe Corporation’s (“Company”) has, pursuant to the terms and conditions of the financing arrangement announced on 22 April 2020, resolved to withdraw the second part of the first convertible notes tranche totaling EUR 250,000 and resolved to issue to Winance in total 250 convertible notes and in total 833,333 warrants related thereto.The Board of Directors of the Company has, pursuant to the terms and conditions of the short-term loan between Valoe and Winance disclosed on 6 February 2020 , resolved to pay the interests totaling EUR 5,000 by converting the interests into convertible notes under the terms and conditions of the financing arrangement between Valoe and Winance...

Continue reading

Valoe Oyj:n ja Winancen välisiin rahoitusjärjestelyihin liittyvät vaihtovelkakirjalainojen ja warranttien liikkeeseenlasku sekä vaihtovelkakirjalainojen vaihtaminen osakkeiksi

Valoe Oyj                                      Pörssitiedote 1.6.2020 klo 16.40  Valoe Oyj:n (“Yhtiö”) hallitus on 22.4.2020 julkistetun Yhtiön ja Winancen välisen rahoitusjärjestelyn ehtojen mukaisesti  päättänyt nostaa rahoitusjärjestelyn ensimmäisen lainaerän toisen osan, määrältään 250.000 euroa sekä päättänyt antaa Winancelle siihen liittyen yhteensä 250 vaihtovelkakirjaa ja 833.333 warranttia.Yhtiön hallitus on päättänyt maksaa Winancelta nostetun, 6.2.2020 julkistetun lyhytaikaisen lainan ehtojen mukaisesti 5.000 euron korot muuttamalla ne 20.12.2018 julkistetun Valoen ja Winancen välisen rahoitusjärjestelyn ehtojen mukaiseksi vaihtovelkakirjalainaksi ja antaa tähän liittyen 5 vaihtovelkakirjaa.Edelleen Yhtiön hallitus on 20.12.2018 julkistetun Valoen ja Winancen välisen rahoitusjärjestelyn ehtojen mukaisesti päättänyt...

Continue reading

Orgenesis to Collaborate with The Edith Wolfson Medical Center to Conduct Clinical Study Using Orgenesis’ Proprietary POCare Technologies for the Generation and Expansion of Tumor Infiltrating Lymphocytes

GERMANTOWN, Md., June 01, 2020 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering, global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs) while lowering costs, today announces that it has entered into a Clinical Study Agreement with The Edith Wolfson Medical Center, a leading public hospital in Israel. Under the agreement, the parties will conduct a clinical study with a goal of utilizing and validating a number of Orgenesis’ proprietary POCare Technologies, including a novel, automated cell culturing system, designed to enable a faster, safer and metabolically optimized culturing and expansion process for the generation and expansion tumor infiltrating lymphocytes (TIL) for use in adoptive T-cell therapies.The...

Continue reading

Pranešimas apie vadovo sandorius

APB „Apranga“ gavo pranešimą apie APB „Apranga“ valdybos nario Vido Lazicko sandorį dėl emitento vertybinių popierių (žr. prisegtą bylą).Saulius Bačauskas„Aprangos“ grupės finansų ir ekonomikos direktorius+370 5 2390843PriedasPranesimas apie emitento vadovu sandorius 2020-06-01

Continue reading

Highwoods to Present at Nareit’s REITweek: 2020 Virtual Investor Conference

RALEIGH, N.C., June 01, 2020 (GLOBE NEWSWIRE) — Highwoods Properties, Inc. (NYSE:HIW) announces Ted Klinck, President and Chief Executive Officer, will participate in a Company roundtable presentation during Nareit’s REITweek: 2020 Virtual Investor Conference. The virtual presentation will take place on Wednesday, June 3, 2020, at 10:45 a.m. ET, and will last approximately 30 minutes. The following is a link to register for Nareit’s REITweek: 2020 Virtual Investor Conference.  To attend the webcast or to view the replay, you must be a registered REITweek attendee.   Complimentary registration is available through today, June 1 after which time there will be a fee.  Once registered, attendees can access the webcast presentation through the conference website.  A replay will be available via your Nareit registration two hours after...

Continue reading

Sirius Acquires Advanced Systems Group

San Antonio, TX, June 01, 2020 (GLOBE NEWSWIRE) — Sirius Computer Solutions, Inc. (Sirius), a leading national IT solutions integrator, announces it has acquired Denver-based Advanced Systems Group (ASG). The acquisition—which closed on May 31—helps Sirius expand its reach in the western region, and marks Sirius’ eighth purchase since 2014, including Brightlight Consulting, Avnet, Inc.’s digital solution services, Varrow, Force 3, thinkASG, Continuum Security Solutions and Forsythe.Founded in 1980, Sirius employs over 2,600 of the brightest minds in the business and a growing team of IT experts that hold more than 5,500 professional and technical certifications. Sirius specializes in helping organizations transform their business by managing their operations, optimizing their IT and securing it all. ASG, founded in 1981, focused primarily...

Continue reading

PROCESSA PHARMACEUTICALS ANNOUNCES THAT IT HAS ENTERED INTO AN AGREEMENT WITH APOSENSE, LTD TO LICENSE IN THE NEXT GENERATION IRINOTECAN DRUG

HANOVER, MD, June 01, 2020 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (OTCQB: PCSA) announced today that it has signed an agreement with Aposense, LTD. to license in the patent rights and the know-how to develop and commercialize their next generation irinotecan cancer drug, ATT-11T.Irinotecan metabolizes to SN-38, the active anti-cancer moiety, and is used as first and second line therapy in many types of cancer (e.g., metastatic colorectal, small cell lung, pancreatic). Although irinotecan has a narrow therapeutic window and dose limiting adverse effects, including a FDA “Black Box” warning for both neutropenia and severe diarrhea, irinotecan achieved peak annual sales of US$1.1 billion.ATT-11T is a novel lipophilic anti-cancer pro-drug that is being developed for the treatment of the same solid tumors as prescribed for...

Continue reading

Ferratum Plc – Managers’ transactions – Kajakas

Ferratum Plc – Managers’ transactions – Kajakas____________________________________________Person subject to the notification requirementName: Kajakas, KristjanPosition: Other senior managerIssuer: Ferratum PlcLEI: 74370078YLPFWHE33716Notification type: INITIAL NOTIFICATIONReference number: 74370078YLPFWHE33716_20200601115830_14____________________________________________Transaction date: 2020-05-28Venue: XETAInstrument type: SHAREISIN: FI4000106299Nature of the transaction: ACQUISITIONTransaction details(1): Volume: 6962 Unit price: 3.9836 EURAggregated transactions(1): Volume: 6962 Volume weighted average price: 3.9836 EUR

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.